With a goal of eradicating hepatitis C, NHS England has teamed up Gilead Sciences Inc., Merck & Co. and AbbVie Inc.
First Year After Launch Special Feature 2018: Don’t look back, someone might be gaining
Approvals, August 2018, Blockbusters, Business, China Food and Drug Administration, Clinical Trials, Collaborations, Diabetes, FDA, FDA/Regulatory, First Year After Launch special feature, Future Blockbusters, Genetic Disorders, Hepatitis C, HIV, Innovation, Neurological Diseases, Potential Blockbusters, Product Launches, StudiesThe top performers of the launch class of 2016 have very little in common – aside from the fact that none of them came from a “classic” big pharma house.
Special Feature: First Year After Launch
August 2016, Biologics, FDA, FDA/Regulatory, Healthcare Communications Agencies, Hepatitis C, Immuno-oncology, Japanese Ministry of Health, Labour and Welfare, Launches, Metastatic Melanoma, Monoclonal Antibodies, Non-Small Cell Lung Cancer (NSCLC), Product Launches, Sales, TherapeuticsThe new generation of hep C drugs has completely changed the conversation about launches.